Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 36

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 36
---
              | 114,771 |     | $            |     -- |     | $     |   468,353 |

| 2) | Represents base salary as described below under “—Employment Agreements.”  From June 2023 to August 2023, Dr. Cobuzzi voluntarily waived his base salary in order to preserve cash resources in advance of the Merger closing. |

| 5) | The amounts reported in this column represent 401(k) Plan matching contributions by the Company. Our NEOs also participate in the Company’s health, dental, vision and life insurance plans, as well as the Company’s health savings account, on the same terms available generally to salaries employees. |

Employment Agreements

John Alam, M.D., President & Chief Executive Officer. Effective February 1, 2024, we entered into an amended and restated employment agreement with Dr. Alam pursuant to which he serves as our President and Chief Executive Officer. Dr. Alam’s annual base salary for the year ended December 31, 2024, was $538,534.86 and his target annual bonus was 50 percent of his base salary. Pursuant to the employment agreement, the Board may increase (but not decrease) Dr. Alam’s base salary at its discretion. In addition, the employment agreement contains certain severance and change of control provisions as described in more detail under the heading “—Post-Termination Severance and Change in Control Arrangements,” non-competition and non-solicitation provisions (each applicable during employment and for 24 months thereafter), and confidentiality and non-disparagement provisions (each applicable during employment and at all times thereafter). The employment agreement has an indefinite term.

<div align='center'>18</div>

Robert J. Cobuzzi, Jr., Ph.D., Chief Operating Officer. Effective February 1, 2024, we entered into an amended and restated employment agreement with Dr. Cobuzzi pursuant to which he serves as our Chief Operating Officer. Dr. Cobuzzi’s annual base salary for the year ended December 31, 2024, was $465,750.00. Pursuant to the employment agreement, the Board may increase (but not decrease) Dr. Cobuzzi’s base salary at its discretion. The employment agreement also provides Dr. Cobuzzi the opportunity to earn a target annual bonus of 50 percent of his base salary. In addition, the employment agreement contains certain severance and change of control provisions as described in more detail under the